Compound information
- Natural Products
- ZC717635
- Molecular Formula
- C21H33N5O5
- Molecular Weight
- 435.248169156 g/mol
- Structure
-
- IUPAC Name
- methyl (2R)-2-[[(2R)-2-(benzyloxycarbonylamino)-5-guanidino-pentanoyl]amino]-4-methyl-pentanoate
- InChI
- InChI=1S/C21H33N5O5/c1-14(2)12-17(19(28)30-3)25-18(27)16(10-7-11-24-20(22)23)26-21(29)31-13-15-8-5-4-6-9-15/h4-6,8-9,14,16-17H,7,10-13H2,1-3H3,(H,25,27)(H,26,29)(H4,22,23,24)/t16-,17-/m1/s1
- InChI Key
- UIESYHDNHVGZRB-IAGOWNOFSA-N
- SMILES
- COC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)OCc1ccccc1
- Source
- ZINC000005957691
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 31 | Ring Count | 1 |
Heteroatom Count | 10 | Rotatable Bond Count | 12 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 5 |
Topological Polar Surface Area | 155.63 Å2 | LogP | 1.787 |
LogS | -2.373 | LogD | 2.039 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.208 | Pgp substrate | 0.996 |
HIA | 0.759 | F20 % | 0.987 |
F30 % | 0.001 | Caco-2 | -5.792 |
MDCK | -5.373 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.739 | PPB | 28.739 |
VD | 0.405 | Fu | 0.502 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.0 | CYP1A2 substrate | 0.566 |
CYP2A6 substrate | 0.249 | CYP2B6 substrate | 0.411 |
CYP2C19 inhibitor | 0.165 | CYP2C19 substrate | 0.455 |
CYP2C8 substrate | 0.509 | CYP2C9 inhibitor | 0.158 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.02 |
CYP2D6 substrate | 0.388 | CYP2E1 substrate | 0.268 |
CYP3A4 inhibitor | 0.501 | CYP3A4 substrate | 0.951 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.756 | CL | 4.848 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.383 | Hepatotoxicity | 0.079 |
Mutagenicity | 0.063 | Rat Oral Acute Toxicity | 0.036 |
FDAMDD | 0.121 | Skin Sensitization | 0.004 |
Carcinogenicity | 0.003 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.048 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.858 | IGC50 | 2.468 |
LC50FM | 3.894 | LC50DM | 3.622 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.169 | NR-AR-LBD | 0.275 |
NR-AhR | 0.003 | NR-Aromatase | 0.023 |
NR-ER | 0.249 | NR-ER-LBD | 0.351 |
NR-PPAR-gamma | 0.208 | SR-ARE | 0.155 |
SR-ATAD5 | 0.302 | SR-HSE | 0.08 |
SR-MMP | 0.009 | SR-p53 | 0.034 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.